Cedar Mountain Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-158
| Closed | -$10.1K | – | 315 |
|
|
2023
Q2 | $10.1K | Hold |
158
| – | – | ﹤0.01% | 167 |
|
|
2023
Q1 | $11K | Hold |
158
| – | – | ﹤0.01% | 158 |
|
|
2022
Q4 | $11.4K | Hold |
158
| – | – | ﹤0.01% | 152 |
|
|
2022
Q3 | $11K | Hold |
158
| – | – | ﹤0.01% | 151 |
|
|
2022
Q2 | $12K | Hold |
158
| – | – | ﹤0.01% | 147 |
|
|
2022
Q1 | $12K | Hold |
158
| – | – | ﹤0.01% | 155 |
|
|
2021
Q4 | $10K | Hold |
158
| – | – | ﹤0.01% | 173 |
|
|
2021
Q3 | $9K | Hold |
158
| – | – | ﹤0.01% | 175 |
|
|
2021
Q2 | $11K | Sell |
158
-1
| -0.6% | -$70 | ﹤0.01% | 159 |
|
|
2021
Q1 | $10K | Hold |
159
| – | – | ﹤0.01% | 167 |
|
|
2020
Q4 | $10K | Hold |
159
| – | – | ﹤0.01% | 172 |
|
|
2020
Q3 | $10K | Hold |
159
| – | – | ﹤0.01% | 156 |
|
|
2020
Q2 | $9K | Buy |
+159
| New | +$9K | ﹤0.01% | 157 |
|